Bastiano Sanna - May 16, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Cell & Genetic Therapies
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
May 16, 2022
Transactions value $
-$11,377
Form type
4
Date filed
5/18/2022, 04:22 PM
Previous filing
May 6, 2022
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale -$1.75K -7 -0.02% $250.56 41.8K May 16, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$2.01K -8 -0.02% $251.37 41.8K May 16, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$1.77K -7 -0.02% $252.43 41.8K May 16, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$3.81K -15 -0.04% $253.99 41.8K May 16, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$2.04K -8 -0.02% $254.44 41.7K May 16, 2022 Direct F1, F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1.
F2 Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $250.56 (range $250.00 to $250.87).
F4 Open market sales reported on this line occurred at a weighted average price of $251.37 (range $251.00 to $251.88).
F5 Open market sales reported on this line occurred at a weighted average price of $252.43 (range $252.15 to $253.07).
F6 Open market sales reported on this line occurred at a weighted average price of $253.99 (range $253.33 to $254.32).
F7 Open market sales reported on this line occurred at a weighted average price of $254.44 (range $254.35 to $254.57).